Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2636
117th Congress(2021-2022)
Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2021
Introduced
Introduced
Introduced in House on Apr 16, 2021
Overview
Text
Introduced in House 
Apr 16, 2021
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Apr 16, 2021)
Apr 16, 2021
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2636 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 2636


To direct the Secretary of Health and Human Services to submit to Congress a report on the security and resilience of the United States medical supply chains, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

April 16, 2021

Mr. Trone (for himself and Mr. Joyce of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To direct the Secretary of Health and Human Services to submit to Congress a report on the security and resilience of the United States medical supply chains, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2021”.

SEC. 2. Report on security and resilience of the United States medical supply chains.

(a) In general.—Not later than one year after the date of the enactment of this Act, and annually thereafter, the Secretary of Health and Human Services shall submit to the Committee on Energy and Commerce of the House of Representatives, and the Committee on Health, Education, Labor and Pensions of the Senate a report on the security and resilience of the United States medical supply chains. Such a report shall contain a classified annex.

(b) Public availability.—The Secretary shall—

(1) make publicly available (including by publication on the website of the Department of Health and Human Services) the unclassified portion of the report under subsection (a); and

(2) make every reasonable effort to protect trade secret information and commercially confidential information.

(c) Contents.—The report submitted under subsection (a) shall—

(1) review the United States supply chains for medical devices, supplies, and drugs and the vulnerability of such supply chains to a global disruption, such as an instance of bioterrorism, a natural disaster, or a public health emergency;

(2) assess the dependence of the United States on any medical devices, equipment, supplies, countermeasures, vaccines, and drugs produced or sourced outside the United States;

(3) identify the actions the Federal government has taken during the year covered by the report—

(A) to promote the security and resilience of the United States medical supply chain;

(B) to improve medical supply chain redundancy;

(C) to encourage the domestic production of medical devices, equipment, supplies, countermeasures, vaccines, and drugs; and

(D) to develop contingency plans for potential global disruptions; and

(4) provide recommendations to agencies of the Federal Government, States, local, tribal, and territorial governments, and the private sector on ways to strengthen the security and resilience of the United States medical supply chain.

(d) Consultation.—In preparing the report under subsection (a), the Secretary of Health and Human Services—

(1) shall consult with the heads of other relevant Federal agencies; and

(2) may consult with public health experts, health security experts, supply chain experts, and other individuals with relevant experience.